JP2023538422A5 - - Google Patents

Info

Publication number
JP2023538422A5
JP2023538422A5 JP2023512669A JP2023512669A JP2023538422A5 JP 2023538422 A5 JP2023538422 A5 JP 2023538422A5 JP 2023512669 A JP2023512669 A JP 2023512669A JP 2023512669 A JP2023512669 A JP 2023512669A JP 2023538422 A5 JP2023538422 A5 JP 2023538422A5
Authority
JP
Japan
Prior art keywords
modified
polypeptide
polypeptide according
sequence
less
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023512669A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023538422A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2021/000574 external-priority patent/WO2022038417A2/en
Publication of JP2023538422A publication Critical patent/JP2023538422A/ja
Publication of JP2023538422A5 publication Critical patent/JP2023538422A5/ja
Pending legal-status Critical Current

Links

JP2023512669A 2020-08-19 2021-08-19 修飾il-18ポリペプチドおよびその使用 Pending JP2023538422A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063067658P 2020-08-19 2020-08-19
US63/067,658 2020-08-19
PCT/IB2021/000574 WO2022038417A2 (en) 2020-08-19 2021-08-19 Modified il-18 polypeptides and uses thereof

Publications (2)

Publication Number Publication Date
JP2023538422A JP2023538422A (ja) 2023-09-07
JP2023538422A5 true JP2023538422A5 (enExample) 2024-08-20

Family

ID=78032459

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023512669A Pending JP2023538422A (ja) 2020-08-19 2021-08-19 修飾il-18ポリペプチドおよびその使用

Country Status (9)

Country Link
US (1) US20220056091A1 (enExample)
EP (1) EP4200323A2 (enExample)
JP (1) JP2023538422A (enExample)
KR (1) KR20230052956A (enExample)
CN (1) CN116368148A (enExample)
AU (1) AU2021327861A1 (enExample)
CA (1) CA3189327A1 (enExample)
IL (1) IL300638A (enExample)
WO (1) WO2022038417A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190070262A1 (en) 2017-09-06 2019-03-07 Yale University Interleukin-18 variants and methods of use
AR123978A1 (es) 2020-11-02 2023-02-01 Simcha Il 18 Inc Variantes de la interleucina-18 y métodos de uso
JP2025508823A (ja) 2022-02-23 2025-04-10 ブライト ピーク セラピューティクス エージー 免疫抗原特異的il-18免疫サイトカイン及びその使用
WO2024044780A1 (en) * 2022-08-26 2024-02-29 Sutro Biopharma, Inc. Interleukin-18 variants and uses thereof
US20240182536A1 (en) * 2022-11-11 2024-06-06 Mural Oncology, Inc. Interleukin 18 variants
WO2025041095A2 (en) * 2023-08-23 2025-02-27 Bright Peak Therapeutics Ag Il-18 polypeptides modified with polymers
US12134635B1 (en) 2023-12-29 2024-11-05 Sonnet BioTherapeutics, Inc. Interleukin 18 (IL-18) variants and fusion proteins comprising same
WO2025151273A1 (en) * 2024-01-08 2025-07-17 Adimab, Llc Il-18 polypeptides and uses thereof
WO2025242835A1 (en) 2024-05-22 2025-11-27 Ose Immunotherapeutics Molecules comprising masking linkers and uses thereof for the treatment of cancer
WO2026083296A1 (en) 2024-10-16 2026-04-23 Bright Peak Therapeutics Ag Trispecific compositions comprising il-18, vegf binding domains, and pd-1 binding domains

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1392830T3 (da) * 2001-03-08 2006-05-08 Ares Trading Sa Interleukin-18 mutanter, deres fremstilling og anvendelse
TW200510454A (en) * 2003-04-15 2005-03-16 Smithkline Beecham Corp Conjugates comprising human IL-18 and substitution mutants thereof
WO2014189370A1 (en) 2013-05-24 2014-11-27 Stichting Katholieke Universiteit Substituted azadibenzocyclooctyne compounds and their use in metal-free click reactions
WO2015112016A1 (en) 2014-01-24 2015-07-30 Synaffix B.V. Process for the cycloaddition of a halogenated 1,3-dipole compound with a (hetero)cycloalkyne
CN121021395A (zh) 2016-06-28 2025-11-28 文塔纳医疗系统公司 点击化学用于ihc和ish测定中的信号扩增的应用
US20190070262A1 (en) * 2017-09-06 2019-03-07 Yale University Interleukin-18 variants and methods of use

Similar Documents

Publication Publication Date Title
TW496870B (en) Compositions methods for stimulating megakaryocyte growth and differentiation
JP2014519852A5 (enExample)
JP2010534486A5 (enExample)
JP2023081303A5 (enExample)
JP2001514858A5 (enExample)
JP2023528207A5 (enExample)
RU2007139915A (ru) Haemophilus influenzae типа в
JP2019196370A5 (enExample)
JP2010518006A5 (enExample)
JP2008505133A5 (enExample)
CN101588820A (zh) α-乳清蛋白组合物
JP2008525033A5 (enExample)
JP2008538183A5 (enExample)
JP2006506942A5 (enExample)
JP2023554379A5 (enExample)
JP2010516290A5 (enExample)
JP2014513941A5 (enExample)
JP2024513559A5 (enExample)
JPH06500114A (ja) 組織再生促進及び癌治療用の生物活性egfペプチド
JP2010513327A5 (enExample)
JP2023529839A5 (enExample)
JP2024535925A5 (enExample)
JP2024525213A5 (enExample)
CN112010959A (zh) αO-芋螺毒素肽GeXIVA新突变体、其药物组合物及用途
JP2009540842A5 (enExample)